Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial

作者：Axel Hauschild, Jean‐Jacques Grob, Лев Вадимович Демидов, Thomas Jouary, Ralf Gutzmer, Michael J. Millward, Piotr Lukasz Rutkowski, Christian U. Blank, Wilson H. Miller, Eckhart Kaempgen, Salvador Martín‐Algarra, Bogusława Karaszewska, Cornelia Mauch, Vanna Chiarion‐Sileni, Anne-Marie Martin, Suzanne Swann, Patricia Haney, Beloo Mirakhur, Mary E. Guckert, Vicki L. Goodman, Paul B. Chapman · 发表于：The Lancet · 年份：2012 · DOI：10.1016/s0140-6736(12)60868-x · 被引用次数：3013 · 研究领域：Melanoma and MAPK Pathways、Cutaneous Melanoma Detection and Management、Chronic Myeloid Leukemia Treatments